Could Novavax Deliver the Best Coronavirus Vaccine?
(Updated 06/14/2021) The Covid-19 vaccine from American biotech company Novavax reported over 90% efficacy in its phase 3 study —whose results have yet to be peer-reviewed—that prioritized patients typically underrepresented in clinical trials, considered to be at high-risk from coronavirus. A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to more than 1.2 million deaths, roiled economies and disrupted billions of lives since it was first identified in China in December. IN EARLY AUGUST, a tiny company won an initial vindication when Novavax announced its strong results from the Australian trial. [3] Later Australia’s Prime Minister Scott Morrison had announced that: [1] Australia government would buy 40 million vaccine doses from Novavax and 10 million from Pfizer and BioNTech. In this article, we will learn more about Novavax’ vaccine ( NVX-CoV2373 ) which is made of nanoparticle studded with the t...